TCRT
Alaunos Therapeutics Inc
NASDAQ: TCRT · HEALTHCARE · BIOTECHNOLOGY
$2.55
-0.39% today
Updated 2026-04-30
Market cap
$6.16M
P/E ratio
—
P/S ratio
1,231.94x
EPS (TTM)
$-2.20
Dividend yield
—
52W range
$2 – $5
Volume
0.0M
Alaunos Therapeutics Inc (TCRT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+21.9%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+13.0%
Last 1 reports
Positive reaction rate
100%
1 of 1 quarters
Largest single-day move
+13.0%
2025-11-14
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-14 | $-0.55 | — | $2.85 | $3.22 | +13.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 | $-0.55 | — | — | — |
| 2025-06-30 | — | $-0.63 | — | — | — |
| 2025-03-31 | — | $-0.67 | — | $2000.00 | +100.0% |
| 2024-12-31 | — | $-0.46 | — | $4000.00 | +300.0% |
| 2024-09-30 | — | $-0.70 | — | — | — |
| 2024-06-30 | — | $-0.71 | — | $4000.00 | +0.0% |
| 2024-03-31 | $-0.45 | $-0.49 | -8.9% | $1000.00 | — |
| 2023-12-31 | $-0.45 | $-0.49 | -8.9% | $1000.00 | — |
| 2023-09-30 | $-0.04 | $-0.04 | +0.0% | — | — |
| 2023-06-30 | $-0.04 | $-0.04 | +0.0% | $4000.00 | — |
| 2023-03-31 | $-0.04 | $-0.04 | +0.0% | — | — |
| 2022-12-31 | $-0.07 | $-0.04 | +42.9% | — | — |
Frequently asked questions
Has Alaunos Therapeutics Inc beaten earnings estimates?
Alaunos Therapeutics Inc has beaten Wall Street EPS estimates in 0 of its last 8 quarterly reports.
How does TCRT stock react to earnings?
TCRT stock has moved an average of +13.0% in the trading day following earnings over its last 1 reports, with positive reactions in 100% of those quarters.